We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Drug habit

18 March 2010 By Alexander Smith

The generic drugs leader has won the auction for the German group with a $4.95 bln cash bid. The deal gives Teva the number two spot in the world’s secondlargest generics market. The price may look toppy at 11.7 times EBITDA, but Teva can squeeze out more savings.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)